REGORAFENIB

Clinical trials for REGORAFENIB explained in plain language.

Never miss a new study

Get alerted when new REGORAFENIB trials appear

Sign up with your email to follow new studies for REGORAFENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo targets hidden cancer cells in colorectal patients

Disease control Terminated

This study tests two drugs, regorafenib and lorigerlimab, in people with high-risk colorectal cancer who have tiny traces of cancer DNA in their blood after finishing standard treatments. The goal is to see if this combination can safely clear those hidden cancer cells. The trial…

Matched conditions: REGORAFENIB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 01, 2026 15:59 UTC

REGORAFENIB

Get alerted when new REGORAFENIB trials appear

New drug combo targets hidden cancer cells in colorectal patients